ACR/ARP 2019 Conference Review, reviewed by A/Prof Andrew Östör

In this review:

Video for self-joint counts in RA
Mining social media for patient perceptions regarding DMARDs
Anifrolumab for moderate to severe SLE
Ianalumab for treatment of Sjögren's syndrome
Upadacitinib for the treatment of AS
Impact of pain on RA remission rates
Filgotinib for the treatment of RA following methotrexate
Switching biologic DMARDs in adalimumab-treated RA patients
Effects of ixekizumab withdrawal in stable PsA patients
Outcomes in female axSpA patients

Please login below to download this issue (PDF)